Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$39.33 USD
+0.90 (2.34%)
Updated Jul 31, 2024 04:00 PM ET
After-Market: $39.36 +0.03 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Earnings News For BHVN
-
Biohaven Ltd. (BHVN) Reports Q3 Loss, Misses Revenue Estimates
-
Biohaven Ltd. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments
-
Biohaven Ltd. (BHVN) Expected to Beat Earnings Estimates: Should You Buy?
-
Biohaven Pharmaceutical (BHVN) Q2 Earnings Lag, Sales Beat
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q2 Loss, Tops Revenue Estimates
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Up 2.8% Since Last Earnings Report: Can It Continue?
-
Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q1 Loss, Tops Revenue Estimates
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Biohaven's (BHVN) Q4 Earnings Miss, Nurtec Gets CHMP Nod
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q4 Loss, Tops Revenue Estimates
-
Will Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Report Negative Earnings Next Week? What You Should Know
-
Biohaven (BHVN) Misses on Q3 Earnings, Inks $1.24B Pfizer Deal
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q3 Loss, Tops Revenue Estimates
-
Will Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Report Negative Q3 Earnings? What You Should Know
-
Why Is Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Up 21.7% Since Last Earnings Report?
-
Biohaven (BHVN) Q2 Earnings Miss, Nurtec Uptake Still Strong
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q2 Loss, Tops Revenue Estimates
-
Analysts Estimate Biohaven Pharmaceutical Holding Company Ltd. (BHVN) to Report a Decline in Earnings: What to Look Out for
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Up 35.3% Since Last Earnings Report: Can It Continue?
-
Biohaven (BHVN) Q1 Earnings Miss, Nurtec Uptake Remains Strong
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q1 Loss, Tops Revenue Estimates (Revised)
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q1 Loss, Tops Revenue Estimates
-
Earnings Preview: Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Q1 Earnings Expected to Decline
-
Biohaven (BHVN) Q4 Earnings Miss, Nurtec Uptake Promising